Details for Patent: 8,899,229
✉ Email this page to a colleague
Which drugs does patent 8,899,229 protect, and when does it expire?
Patent 8,899,229 protects ONZETRA XSAIL and is included in one NDA.
This patent has twenty patent family members in seven countries.
Summary for Patent: 8,899,229
| Title: | Powder delivery devices |
| Abstract: | A nasal delivery device for delivering substance to a nasal cavity of a subject, the delivery device comprising: a substance supply unit for supplying a dose of substance to be delivered to the nasal cavity of the subject, the substance supply unit including an inlet and an outlet; a nosepiece unit including a nosepiece for fitting to a nasal cavity of the subject and being in fluid communication with the outlet of the substance supply unit; and a mouthpiece unit including a mouthpiece in fluid communication with the inlet of the substance supply unit and through which the subject in use exhales such as to entrain substance from the container chamber and deliver the same through the nosepiece, and at least one temperature modifier for reducing a temperature of the exhaled air flow such as to reduce the absolute humidity thereof. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO), Hafner; Roderick Peter (Swindon, GB), Sheldrake; Colin David (Oxfordshire, GB) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 11/816,984 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; Dosage form; |
Drugs Protected by US Patent 8,899,229
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,899,229
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0503738.7 | Feb 23, 2005 |
| PCT Information | |||
| PCT Filed | February 23, 2006 | PCT Application Number: | PCT/GB2006/000631 |
| PCT Publication Date: | August 31, 2006 | PCT Publication Number: | WO2006/090149 |
International Family Members for US Patent 8,899,229
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006217724 | ⤷ Try a Trial | |||
| Canada | 2598953 | ⤷ Try a Trial | |||
| Canada | 2918226 | ⤷ Try a Trial | |||
| China | 101217992 | ⤷ Try a Trial | |||
| China | 103463716 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
